ADVANCE: An Observational Study To Determine Bortezomib Safety and Effectiveness at First Relapse After Participation In First Line HOVON-49/50 Clinical Studies.
This study has been terminated.
(Recruitment too slow. Number of eligible patients probably to low. Patients enrolled and/or in follow-up will be followed up in the Valeo study.)
Information provided by:
First received: February 26, 2007
Last updated: November 4, 2010
Last verified: November 2010
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been terminated.|
|Estimated Study Completion Date:||July 2011|
|Estimated Primary Completion Date:||No date given|